Clinical trial
Anticoagulation and Inferior Vena Cava Filters in Cancer Patients With a Venous…
NCT00423683 · Northwell Health, Other · Terminated
Key facts
| NCT number | NCT00423683 |
|---|---|
| Title | Anticoagulation and Inferior Vena Cava Filters in Cancer Patients With a Venous Thromboembolism |
| Official title | A Randomized Control Trial of Anticoagulation and Inferior Vena Cava Filters in Cancer Patients With A Venous Thromboembolism |
| Lead sponsor | Northwell Health, Other |
| Collaborators | GlaxoSmithKline Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Cancer, Thromboembolism |
| Intervention type | Device, Drug |
| Interventions | Arixtra alone, Arixtra + filter |
| Enrollment | 64 |
| Start date | Jan 1, 2007 |
| Primary completion | Nov 1, 2010 |
| Completion | Nov 1, 2010 |
| First posted | Jan 18, 2007 |
| Last update posted | Jun 8, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: